ARCHIVES

FDA Describes Meeting With NCI In “Limited” Memo

This article is from The Cancer Letter archive.

Vol. 02 No. 19 | May 7, 1976

Download PDF Visit The Full Archive

Related Articles

House, Senate Must Resolve Major Differences In Authorization Bills

September 12, 1980

Senate Subcommittee Gives NCI 41.397 Billion for FY ‘87

August 8, 1986

Hatch Hearing Turns Up Few New Deficiencies In NCI Contract Management; DeVita Blasted On Strauss

June 5, 1981

ADT May Increase Risk Of Cardio Events In Prostate Cancer Patients

February 5, 2010

Payline Not Set For CCOPs Yet In Recompetition

March 1, 1991

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

October 26, 1984